Iridex (IRIX) Divestments (2012 - 2013)

Iridex's (IRIX) quarterly Divestments came in at $510000.0 in Q2 2013, down 88.99% quarter-over-quarter from $4.6 million in Q1 2012.

Iridex (IRIX) Divestments (2012 - 2013) Analysis & Trends

Iridex's Divestments history runs 2 years deep, the most recent figure standing at $510000.0 for Q2 2013.

  • On a quarterly basis, Divestments changed N/A year-over-year to $510000.0 in Q2 2013; TTM through Dec 2013 was $510000.0, a 88.99% decrease from a year earlier, with the FY2013 full-year figure at $510000.0, down 88.99% from the prior year.
  • Divestments slipped to $510000.0 in Q2 2013 per IRIX's latest filing, from $4.6 million in the prior quarter.
  • Across five years, Divestments topped out at $4.6 million in Q1 2012 and bottomed at $510000.0 in Q2 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.37 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Iridex 15.93 Mn 11.33 Mn 4.74 Mn -

Historic Data

Download Data
DateValue
Jun 29, 2013 510,000.00
Mar 31, 2012 4.63 Mn